RAD 601
Alternative Names: RAD-601Latest Information Update: 16 Jun 2022
At a glance
- Originator Case Western Reserve University School of Medicine
- Developer Radiopharm Theranostics
- Class Diagnostic agents; Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Glioblastoma
Most Recent Events
- 09 Jun 2022 Radiopharm Theranostics sub-licenses PTPµ-targeted radiopharmaceutical agent from NeoIndicate
- 09 Jun 2022 Case Western Reserve University has patent protection for NEO-001 technology
- 09 Jun 2022 Preclinical trials in Glioblastoma (Diagnosis) in Australia (Parenteral) (Radiopharm Theranostics pipeline, June 2022)